(Q41647250)

6 October 2017

A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus (English)

1 reference

6 October 2017

1 reference

Hanly JG

1

1 reference

6 October 2017

Hong C

series ordinal

2

1 reference

6 October 2017

Smith S

series ordinal

3

1 reference

6 October 2017

Fisk JD

series ordinal

4

1 reference

6 October 2017

1 April 1999

1 reference

6 October 2017

Arthritis & Rheumatology

1 reference

6 October 2017

42

1 reference

6 October 2017

4

1 reference

6 October 2017

728-734

1 reference

The neuropsychiatric manifestations of systemic lupus erythematosus: an overview

6 October 2017

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

Psychiatric disorder and cognitive impairment in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

Cognitive disorders in systemic lupus erythematosus. Epidemiologic and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationships with clinical manifestations and disease activity in an Italian series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

A Controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A4%3C728%3A%3AAID-ANR16%3E3.0.CO%3B2-O

10.1002/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference